Clinical trial
A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG Laser System Transmyocardial Revascularization for Angina Reduction
NCT01827319 is registered in ClinicalTrials.gov with Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG Laser System Transmyocardial Revascularization for Angina Reduction
- Lead sponsor
- Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- June 30, 2015
- Enrollment
- 203 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
class iv angina